This launch represents an important step in Roche’s personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine.
Each year 300,000 patients around the world are diagnosed with triple-negative breast cancer, an aggressive disease with limited treatment options1,2
VENTANA PD-L1 (SP142) Assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that OncoMyx Therapeutics, Inc. has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.Continue reading
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that GT Medical Technologies, Inc. (GT MedTech) has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.Continue reading
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced the final line up for the fourth annual Arizona Bioscience Week which will begin on September 30, 2019 and conclude on October 4, 2019.Continue reading
AQUALUNG THERAPEUTICS CORPORATION receives a $225,000 National Institutes of Health (NIH) (award number R41 HL147769-01) Grant to establish a novel panel of Acute Respiratory Distress Syndrome (ARDS) biomarkers (CRIT-ICU Panel) that stratifies subjects at risk for ARDS into high and low mortality sub-groups.
The discovery by Dr. Shaowen Bao and his colleagues could lead to new treatments to silence tinnitus for millions of sufferers.Continue reading
The Arizona Bioindustry Association (AZBio) today announced that the Honorable Debbie McCune Davis, Executive Director of The Arizona Partnership for Immunization will receive the AZBio Public Service Award in recognition of her accomplishments during four decades of service to the community at the AZBio Awards on October 2, 2019.Continue reading
Gholam Peyman, MD, Discusses Device That Reads Eye Prescriptions Faster, Cheaper and More Accurately
Renowned retina surgeon Gholam Peyman, MD, a professor at the University of Arizona College of Medicine – Phoenix best known for his invention of LASIK eye surgery, is making another breakthrough in the eye industry.Continue reading
